Mmastodon BusinessBusiness first seen 8 h ago, last 8 h ago, peak #5

AstraZeneca invests $2bn in cancer drug partnership with Summit Therapeutics

Original: 📈 Astrazeneca invests $2bn in cancer drug tie-up Astrazeneca has invested $2bn in US pharmaceutical firm Summit Therapeu

AstraZeneca has invested $2bn in US biotech firm Summit Therapeutics as part of a major cancer research collaboration. The FTSE 100 drugmaker agreed to buy 109,000 shares in the Nasdaq-listed company at $18.36 per share, funding a tie-up aimed at developing new cancer treatments.

Why now: The large investment and high-profile oncology partnership between two drugmakers is fresh business news drawing attention.

AstraZenecaSummit Therapeutics

Open on mastodon →

Evidence

• 📈 Astrazeneca invests $2bn in cancer drug tie-up Astrazeneca has invested $2bn in US pharmaceutical firm Summit Therapeutics as part of a blockbuster cancer research tie-up. The FTSE 100 drugs giant has agreed to buy 109,000 shares in Nasdaq-listed Summit for $18.36 per share… · viewlinemedia · 1

API: https://socialmediatrends-api.osmike.com/v1/trends/333906